Valneva SE (EPA:VLA)
2.916
+0.086 (3.04%)
May 12, 2025, 5:35 PM CET
Valneva SE Revenue
Valneva SE had revenue of 49.23M EUR in the quarter ending March 31, 2025, with 50.31% growth. This brings the company's revenue in the last twelve months to 186.06M, up 21.64% year-over-year. In the year 2024, Valneva SE had annual revenue of 169.58M with 10.32% growth.
Revenue (ttm)
186.06M
Revenue Growth
+21.64%
P/S Ratio
2.62
Revenue / Employee
260.95K
Employees
713
Market Cap
487.40M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 169.58M | 15.87M | 10.32% |
Dec 31, 2023 | 153.71M | -207.59M | -57.46% |
Dec 31, 2022 | 361.30M | 13.22M | 3.80% |
Dec 31, 2021 | 348.09M | 237.76M | 215.52% |
Dec 31, 2020 | 110.32M | -15.88M | -12.58% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sanofi | 45.17B |
EssilorLuxottica Société anonyme | 26.51B |
Sartorius Stedim Biotech | 2.86B |
bioMérieux | 3.98B |
Eurofins Scientific SE | 6.95B |
Ipsen | 3.57B |
Virbac | 1.40B |
emeis Société anonyme | 5.64B |
Valneva SE News
- 1 day ago - Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States - GlobeNewsWire
- 3 days ago - Valneva SE (VALN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Valneva SE 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 4 days ago - Valneva reports Q1 results - Seeking Alpha
- 5 days ago - Valneva SE: Still Undervalued Travel Vaccine Bet With Robust 2025 Guidance - Seeking Alpha
- 5 days ago - Valneva dips as EU suspends use of chikungunya shot in older adults - Seeking Alpha
- 5 days ago - Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly - GlobeNewsWire
- 5 days ago - Europe reviews Valneva's chikungunya vaccine after reports of serious side-effects in older people - Reuters